Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04318327
Title BCMA-directed CAR-T Cell Therapy in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR | AUS

Facility Status City State Zip Country Details
University of Chicago Medical Center Hematology and Oncology Chicago Illinois 60637 United States Details
University of Kansas Cancer Center . Westwood Kansas 66205 United States Details
Beth Israel Deaconess Medical Cente KS121 Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Main Centre Boston Massachusetts 02215 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
Novartis Investigative Site Prahran Victoria 3181 Australia Details
Novartis Investigative Site Camperdown NSW Australia Details
Novartis Investigative Site Haifa 3109601 Israel Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field